$SINT
Sintx Technologies, Inc.

2015 Q1 Form 10-K Financial Statement

#000156459015001941 Filed on March 24, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014
Revenue $4.743M $5.150M $22.77M
YoY Change -17.94% -9.81% 2.04%
Cost Of Revenue $1.522M $2.720M $7.910M
YoY Change -7.7% 78.95% 37.57%
Gross Profit $3.221M $2.430M $14.86M
YoY Change -22.03% -42.0% -2.71%
Gross Profit Margin 67.91% 47.18% 65.24%
Selling, General & Admin $5.384M $5.140M $32.28M
YoY Change -29.12% -13.61% 45.8%
% of Gross Profit 167.15% 211.52% 217.3%
Research & Development $1.843M $1.140M $6.740M
YoY Change 211.84% 93.22% 94.8%
% of Gross Profit 57.22% 46.91% 45.37%
Depreciation & Amortization $428.0K $590.0K $1.839M
YoY Change -1.15% 9.26% 7.8%
% of Gross Profit 13.29% 24.28% 12.38%
Operating Expenses $7.227M $6.280M $39.03M
YoY Change -11.73% -4.12% 52.44%
Operating Profit -$4.006M -$3.850M -$24.18M
YoY Change -1.23% 63.14% 133.91%
Interest Expense $1.100M -$3.030M -$3.890M
YoY Change 107.55% -183.7% -310.16%
% of Operating Profit
Other Income/Expense, Net -$1.375M -$2.220M -$8.415M
YoY Change 109.28% 2366.67% -510.69%
Pretax Income -$5.381M -$9.700M -$32.58M
YoY Change 14.17% -1569.7% 293.22%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.381M -$9.700M -$32.58M
YoY Change 14.17% -1569.7% 293.22%
Net Earnings / Revenue -113.45% -188.35% -143.09%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.079B -$2.941B -$14.38B
COMMON SHARES
Basic Shares Outstanding 26.76M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.88M $18.25M $18.25M
YoY Change 12.22% 700.66% 700.44%
Cash & Equivalents $14.88M $18.25M $18.25M
Short-Term Investments $0.00
Other Short-Term Assets $1.460M $1.250M $1.250M
YoY Change -27.36% -73.63% -73.63%
Inventory $11.20M $11.68M $11.68M
Prepaid Expenses
Receivables $2.568M $2.513M $2.510M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.11M $33.68M $33.68M
YoY Change 2.2% 69.17% 69.16%
LONG-TERM ASSETS
Property, Plant & Equipment $3.286M $3.515M $3.520M
YoY Change -9.33% -0.45% -0.28%
Goodwill $6.163M $6.163M
YoY Change 0.0% 0.0%
Intangibles $4.063M $4.188M
YoY Change -10.96% -10.67%
Long-Term Investments
YoY Change
Other Assets $35.00K $35.00K $40.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $13.55M $13.90M $13.90M
YoY Change -5.83% -3.58% -3.61%
TOTAL ASSETS
Total Short-Term Assets $30.11M $33.68M $33.68M
Total Long-Term Assets $13.55M $13.90M $13.90M
Total Assets $43.66M $47.58M $47.58M
YoY Change -0.43% 38.62% 38.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.217M $778.0K $780.0K
YoY Change -46.51% -76.96% -76.92%
Accrued Expenses $3.117M $3.146M $3.090M
YoY Change -21.37% -15.23% -16.03%
Deferred Revenue
YoY Change
Short-Term Debt $19.16M $19.07M $19.07M
YoY Change 18.78% 6.36% 6.36%
Long-Term Debt Due $19.16M $19.07M
YoY Change 18.75% 6.39%
Total Short-Term Liabilities $23.49M $22.99M $22.99M
YoY Change 5.01% -8.07% -8.08%
LONG-TERM LIABILITIES
Long-Term Debt $3.110M $3.061M $3.060M
YoY Change
Other Long-Term Liabilities $134.0K $134.0K $14.62M
YoY Change 0.0% 0.0% 1489.13%
Total Long-Term Liabilities $3.244M $3.195M $17.68M
YoY Change 2320.9% 2284.33% 1821.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.49M $22.99M $22.99M
Total Long-Term Liabilities $3.244M $3.195M $17.68M
Total Liabilities $26.74M $26.19M $40.68M
YoY Change 18.8% 4.14% 56.88%
SHAREHOLDERS EQUITY
Retained Earnings -$177.9M -$172.5M
YoY Change 22.99% 23.29%
Common Stock $291.0K $179.4M
YoY Change 134.68% -1465.6%
Preferred Stock
YoY Change
Treasury Stock (at cost) $120.0K $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $3.180M $6.910M $6.910M
YoY Change
Total Liabilities & Shareholders Equity $43.66M $47.58M $47.58M
YoY Change -0.43% 38.62% 38.6%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014
OPERATING ACTIVITIES
Net Income -$5.381M -$9.700M -$32.58M
YoY Change 14.17% -1569.7% 293.22%
Depreciation, Depletion And Amortization $428.0K $590.0K $1.839M
YoY Change -1.15% 9.26% 7.8%
Cash From Operating Activities -$2.970M -$3.090M -$14.52M
YoY Change 48.5% -30.72% 45.93%
INVESTING ACTIVITIES
Capital Expenditures $277.0K -$140.0K $2.172M
YoY Change -49.45% -81.58% -6.86%
Acquisitions
YoY Change
Other Investing Activities $0.00 $20.00K $440.0K
YoY Change -100.0% -140.0% -83.01%
Cash From Investing Activities -$270.0K -$130.0K -$1.740M
YoY Change -54.24% -84.15% -796.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $120.0K $15.37M
YoY Change -100.78%
Debt Paid & Issued, Net $0.00 $19.00M
YoY Change -100.0%
Cash From Financing Activities -120.0K 11.11M 32.23M
YoY Change -100.88% 249.19%
NET CHANGE
Cash From Operating Activities -2.970M -3.090M -14.52M
Cash From Investing Activities -270.0K -130.0K -1.740M
Cash From Financing Activities -120.0K 11.11M 32.23M
Net Change In Cash -3.360M 7.890M 15.97M
YoY Change -130.6% -249.43% -3497.87%
FREE CASH FLOW
Cash From Operating Activities -$2.970M -$3.090M -$14.52M
Capital Expenditures $277.0K -$140.0K $2.172M
Free Cash Flow -$3.247M -$2.950M -$16.69M
YoY Change 27.43% -20.27% 35.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26756808
CY2014Q2 dei Entity Public Float
EntityPublicFloat
48738000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18247000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2279000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
392000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2513000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2817000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1247000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1575000
CY2013Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2763000
CY2014Q4 us-gaap Inventory Net
InventoryNet
11675000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-305000
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4188000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4688000
CY2014Q4 us-gaap Goodwill
Goodwill
6163000
CY2013Q4 us-gaap Goodwill
Goodwill
6163000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3711000
CY2014Q4 us-gaap Assets
Assets
47583000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3146000
CY2013Q4 us-gaap Assets
Assets
34327000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
778000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3377000
CY2013Q4 us-gaap Inventory Net
InventoryNet
10084000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
33682000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
19910000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3515000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3531000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
19070000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
17925000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22994000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25013000
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
517000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
575000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3061000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
134000
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13970000
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
210000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
161456000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
264000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179148000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-13144000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172505000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139923000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6907000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-153061000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47583000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34327000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
54000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
49000
CY2014Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
130000000
CY2014Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2013Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
80910394
CY2014Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2013Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
80910394
CY2014Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0
CY2013Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
149692000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26353666
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
22314000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
597675
CY2013 us-gaap Interest Expense
InterestExpense
1851000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
597675
CY2014 us-gaap Gross Profit
GrossProfit
14855000
CY2013 us-gaap Gross Profit
GrossProfit
15269000
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16384000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-10335000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
16000
CY2013 us-gaap Operating Expenses
OperatingExpenses
25604000
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26353666
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2194000
CY2014 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-251000
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3970000
CY2014 amda Offering Cost
OfferingCost
2026000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-306000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-86000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8415000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2049000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32582000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8286000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-32582000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8286000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32582000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8288000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.66
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-15.52
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12239953
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
534073
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-148283000
CY2013 amda Issuance Of Common Stock Upon Exercise Of Warrants Amount
IssuanceOfCommonStockUponExerciseOfWarrantsAmount
2878000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
555000
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
162432000
CY2014 amda Issuance Of Common Stock Upon Exercise Of Warrants Amount
IssuanceOfCommonStockUponExerciseOfWarrantsAmount
24000
CY2014 amda Issuance Of Common Stock With Notes Payable Value
IssuanceOfCommonStockWithNotesPayableValue
220000
CY2014 amda Issuance Of Common Stock Upon Conversion Of Notes Payable Value
IssuanceOfCommonStockUponConversionOfNotesPayableValue
2428000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11001000
CY2014 us-gaap Depreciation
Depreciation
1839000
CY2013 us-gaap Depreciation
Depreciation
1706000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
501000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
501000
CY2014 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
20000
CY2013 us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
20000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1849000
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
431000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
10217000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
555000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3289000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14522000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3438000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9949000
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-81000
CY2014 amda Provision For Inventory Reserve
ProvisionForInventoryReserve
2630000
CY2013 amda Provision For Inventory Reserve
ProvisionForInventoryReserve
1293000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-239000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1194000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2775000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4220000
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2551000
CY2013 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3413000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2172000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2332000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
43000
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
37000
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-392000
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
132000
CY2013 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2680000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1737000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
253000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15369000
CY2014 amda Proceeds From Issuance Of Units
ProceedsFromIssuanceOfUnits
11320000
CY2013 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2878000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
77000
CY2013 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
8852000
CY2013 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10940000
CY2013 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
13513000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
19000000
CY2014 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
810000
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
26800000
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1452000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
32227000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9234000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15968000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-462000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2741000
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
161456000
CY2014 amda Reclassification Of Warrant Liability
ReclassificationOfWarrantLiability
5000
CY2014 amda Stock And Derivative Liabilities Issued With Long Term Debt
StockAndDerivativeLiabilitiesIssuedWithLongTermDebt
3477000
CY2014 amda Debt Converted To Common Stock
DebtConvertedToCommonStock
1500000
CY2013 amda Derivative Liabilities Issued With Preferred Stock
DerivativeLiabilitiesIssuedWithPreferredStock
871000
CY2014 us-gaap Interest Paid
InterestPaid
1731000
CY2013 us-gaap Interest Paid
InterestPaid
1403000
CY2014 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amedica Corporation (&#8220;Amedica&#8221; or &#8220;the Company&#8221;) was incorporated in the state of Delaware on December&#160;10, 1996. Amedica is a commercial-stage biomaterial company focused on using its silicon nitride technology platform to develop, manufacture, and commercialize a broad range of medical devices. The Company believes it is the first and only manufacturer to use silicon nitride in medical applications. The Company acquired US Spine, Inc. (&#8220;US Spine&#8221;), a Delaware spinal products corporation with operations in Florida, on September&#160;20, 2010. The Company&#8217;s products are primarily sold in the U.S.</p></div>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. Some of the more significant estimates relate to inventory, stock-based compensation, long-lived and intangible assets, and derivative liabilities. </p></div>
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and Significant Customers </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, accounts receivable and restricted cash. The Company limits its exposure to credit loss by placing its cash and cash equivalents with high credit-quality financial institutions in bank deposits, money market funds, U.S. government securities and other investment grade debt securities that have strong credit ratings. The Company has established guidelines relative to diversification of its cash and marketable securities and their maturities that are intended to secure safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates and changes in the Company&#8217;s operations and financial position. Although the Company may deposit its cash and cash equivalents with multiple financial institutions, its deposits, at times, may exceed federally insured limits. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s customers are primarily hospitals and surgical centers. At December&#160;31, 2014, no customer receivable balance was 10% or greater of the Company&#8217;s total trade accounts receivable. At December&#160;31, 2013, one customer receivable balance was 15% of the Company&#8217;s total trade accounts receivable. There were two customers that accounted for 10% or more of the Company&#8217;s revenue representing 28% of revenue for the year ended December&#160;31, 2014. There was one customer that accounted for 10% or more of the Company&#8217;s revenue representing 14% of revenue for the year ended December&#160;31, 2013. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credit to customers is granted based upon an analysis of the customers&#8217; individual credit worthiness. The Company&#8217;s allowance for bad debts as of December&#160;31, 2014 and 2013 was $54,000 and $49,000, respectively. For the years ended December&#160;31, 2014 and 2013, the Company recorded bad debt expense of $65,000 and $5,000, respectively. </p></div>
CY2013 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2014 us-gaap Advertising Expense
AdvertisingExpense
149000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27872356
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4736809
CY2013 us-gaap Advertising Expense
AdvertisingExpense
403000
CY2014 us-gaap Liquidity Disclosure Sufficient Cash And Waivers Note
LiquidityDisclosureSufficientCashAndWaiversNote
As discussed further in Note 7, the Company refinanced its long-term debt and entered into a term loan with Hercules Technology Growth Capital, Inc. (“Hercules Technology”), as administrative and collateral agent for the lenders thereunder and as lender, and Hercules Technology III, LP, as lender (the “Hercules Term Loan”). The Hercules Term Loan has a liquidity covenant that requires the Company to maintain a cash balance in excess of $9.0 million
CY2014Q4 us-gaap Cash
Cash
18200000
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0388
CY2014 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
54000
CY2013 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
49000
CY2013Q1 amda Percentage Of Excise Tax Included In Cost Of Revenue
PercentageOfExciseTaxIncludedInCostOfRevenue
0.023
CY2014 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2014 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2013 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2014 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2013 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2014 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2014 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2013 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2014Q4 amda Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
1439000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
839000
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1025000
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
486000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17751000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15041000
CY2014Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
3000000
CY2013Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
5500000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18556000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4899000
CY2014Q4 amda Finite Lived Intangible Assets Amortization Expense Year One
FiniteLivedIntangibleAssetsAmortizationExpenseYearOne
501000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
501000
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1410000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10350000
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7649000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14220000
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
9587000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
9587000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5399000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
501000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
501000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
501000
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1500000
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0
CY2013Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0
CY2014Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2013Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2014Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2013Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2014Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2013Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2014Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2013Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2014Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2700000
CY2013 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
2000
CY2014Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
846000
CY2013Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
989000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1001000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
645000
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
531000
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
277000
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
333000
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
119000
CY2014Q4 amda Accrued Final Loan Payment Fees Current
AccruedFinalLoanPaymentFeesCurrent
233000
CY2013Q4 amda Accrued Final Loan Payment Fees Current
AccruedFinalLoanPaymentFeesCurrent
1281000
CY2013Q4 amda Accrued Offering Costs Current
AccruedOfferingCostsCurrent
323000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
57000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
32000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
145000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
45000
CY2014 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2047082
CY2014Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
24500000
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
18000000
CY2014Q4 amda Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
20000000
CY2013Q4 amda Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
18000000
CY2014Q4 amda Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
4500000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
22131000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
17925000
CY2014 amda Maximum Denominator To Calculate Conversion Ratio
MaximumDenominatorToCalculateConversionRatio
8.00
CY2014 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50583
CY2014 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
50000
CY2014 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
444403
CY2014 amda Issuance Of Common Stock Upon Exercise Of Warrants Shares
IssuanceOfCommonStockUponExerciseOfWarrantsShares
9328
CY2013Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
3884788
CY2014 us-gaap Dividends
Dividends
0
CY2013 us-gaap Dividends
Dividends
0
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2369000
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
75000
CY2014Q4 amda Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
930000
CY2013Q4 amda Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
75000
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
27872356
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4828468
CY2013Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
100000000
CY2014 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
Unless an affirmative vote of 50% of the combined outstanding shares of preferred stock, voting separately as a class, is obtained, the Company shall not undertake any of the following: (i) declaration or payment of any dividend or other distribution or payment on the (or the redemption, purchase or other acquisition for value of any) capital stock of the Company or any subsidiary; (ii) any liquidation, dissolution, recapitalization or reorganization of the Company; (iii) transfer or disposition of assets or rights with a value of more than $1,000,000; and/or (iv) any amendment to the Company’s certificate of incorporation that changes or alters any of the preferences, voting powers or other rights and privileges of preferred stock.
CY2014 amda Percentage Of Affirmative Vote By Shareholders
PercentageOfAffirmativeVoteByShareholders
0.50
CY2014 amda Assets Transferred To Held For Disposition During Period
AssetsTransferredToHeldForDispositionDuringPeriod
1000000
CY2014 amda Registration Rights Descriptions
RegistrationRightsDescriptions
The preferred stockholders and warrant holders were granted registration rights that provide these holders the right to request, beginning 180 days after the completion of a qualifying initial public offering, that the Company file a registration statement to register under the Securities Act the common stock that would be issued upon conversion of the preferred shares or exercise of the warrants.
CY2014 amda Registration Rights Period
RegistrationRightsPeriod
P180D
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
106544
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1448751
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
157102
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
14714
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1383479
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
339110
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1327485
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.90
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.30
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.84
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.54
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.13
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.42
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.22
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M12D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y2M12D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18600
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
17700
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11001000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
555000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.043
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.043
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.007
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.030
CY2014 amda Effective Income Tax Rate Reconciliation Equity Related Expenses Benefit
EffectiveIncomeTaxRateReconciliationEquityRelatedExpensesBenefit
0.029
CY2013 amda Effective Income Tax Rate Reconciliation Equity Related Expenses Benefit
EffectiveIncomeTaxRateReconciliationEquityRelatedExpensesBenefit
-0.050
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.361
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.463
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
50673000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42661000
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
60000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
17000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2587000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2350000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6057000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2823000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59377000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47851000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
918000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1028000
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
918000
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1028000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
58459000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46823000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
962000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
980000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
830000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
58593000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46957000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-134000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-134000
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
132500000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
111500000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11700000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3800000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
810000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
883000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
910000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
938000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4673000
CY2014 us-gaap Operating Leases Indemnification Agreements Description
OperatingLeasesIndemnificationAgreementsDescription
These agreements generally continue until the later of (a) ten years from the date of the agreements, and (b) the expiration of the patent rights relating to the devices covered by the agreements, when rights have been assigned by the individuals to the Company.
CY2014 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P10Y
CY2014 us-gaap Royalty Expense
RoyaltyExpense
1300000
CY2013 us-gaap Royalty Expense
RoyaltyExpense
892000
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
164000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
162000

Files In Submission

Name View Source Status
0001564590-15-001941-index-headers.html Edgar Link pending
0001564590-15-001941-index.html Edgar Link pending
0001564590-15-001941.txt Edgar Link pending
0001564590-15-001941-xbrl.zip Edgar Link pending
amda-10k_20141231.htm Edgar Link pending
amda-20141231.xml Edgar Link completed
amda-20141231.xsd Edgar Link pending
amda-20141231_cal.xml Edgar Link unprocessable
amda-20141231_def.xml Edgar Link unprocessable
amda-20141231_lab.xml Edgar Link unprocessable
amda-20141231_pre.xml Edgar Link unprocessable
amda-ex231_20141231432.htm Edgar Link pending
amda-ex232_20141231433.htm Edgar Link pending
amda-ex311_201412316.htm Edgar Link pending
amda-ex312_201412317.htm Edgar Link pending
amda-ex32_201412318.htm Edgar Link pending
amda-ex427_20141231434.htm Edgar Link pending
amda-ex428_20141231435.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g20150324203309346497.jpg Edgar Link pending
g20150324203309439498.jpg Edgar Link pending
g20150324203309455499.jpg Edgar Link pending
g20150324203309471500.jpg Edgar Link pending
g20150324203310033501.jpg Edgar Link pending
g20150324203311314502.jpg Edgar Link pending
g20150324203311596503.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending